Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780
Clinical trial NCT06576765 · COMPLETED
Trial details
- NCT number
- NCT06576765
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-08
- Primary completion
- 2024-11-08
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.